These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26475334)

  • 1. Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance.
    Li B; Xu WW; Guan XY; Qin YR; Law S; Lee NP; Chan KT; Tam PY; Li YY; Chan KW; Yuen HF; Tsao SW; He QY; Cheung AL
    Clin Cancer Res; 2016 Mar; 22(5):1243-55. PubMed ID: 26475334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Id1-induced IGF-II and its autocrine/endocrine promotion of esophageal cancer progression and chemoresistance--implications for IGF-II and IGF-IR-targeted therapy.
    Li B; Tsao SW; Chan KW; Ludwig DL; Novosyadlyy R; Li YY; He QY; Cheung AL
    Clin Cancer Res; 2014 May; 20(10):2651-62. PubMed ID: 24599933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor of Differentiation/DNA Binding 1 (ID1) Inhibits Etoposide-induced Apoptosis in a c-Jun/c-Fos-dependent Manner.
    Zhao Y; Luo A; Li S; Zhang W; Chen H; Li Y; Ding F; Huang F; Liu Z
    J Biol Chem; 2016 Mar; 291(13):6831-42. PubMed ID: 26858249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
    Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
    J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation-inducing factor-1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and thymidylate synthase mRNAs accumulation.
    Sprio AE; Di Scipio F; Ceppi P; Salamone P; Di Carlo F; Scagliotti GV; Papotti M; Ceccarelli A; Berta GN
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):983-9. PubMed ID: 22139443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness.
    Xu WW; Li B; Zhao JF; Yang JG; Li JQ; Tsao SW; He QY; Cheung ALM
    Cancer Lett; 2018 Jul; 425():88-100. PubMed ID: 29604392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic alterations of the Igf2 promoter and the effect of miR‑483‑5p on its target gene expression in esophageal squamous cell carcinoma.
    Zhang H; Shi X; Chang W; Li Y; Wang L; Wang L
    Mol Med Rep; 2018 Feb; 17(2):2251-2256. PubMed ID: 29207103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma.
    Song C; Lu P; Shi W; Sun G; Wang G; Huang X; Wang Z; Wang Z
    Biomed Pharmacother; 2016 Oct; 83():843-849. PubMed ID: 27501502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-203 is a direct transcriptional target of E2F1 and causes G1 arrest in esophageal cancer cells.
    Zhang K; Dai L; Zhang B; Xu X; Shi J; Fu L; Chen X; Li J; Bai Y
    J Cell Physiol; 2015 Apr; 230(4):903-10. PubMed ID: 25216463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
    Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H
    Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
    Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-615-5p targets insulin-like growth factor 2 and exerts tumor-suppressing functions in human esophageal squamous cell carcinoma.
    Yang B; Xie R; Wu SN; Gao CC; Yang XZ; Zhou JF
    Oncol Rep; 2018 Jan; 39(1):255-263. PubMed ID: 29115555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma.
    Zhang HF; Chen Y; Wu C; Wu ZY; Tweardy DJ; Alshareef A; Liao LD; Xue YJ; Wu JY; Chen B; Xu XE; Gopal K; Gupta N; Li EM; Xu LY; Lai R
    Clin Cancer Res; 2016 Feb; 22(3):691-703. PubMed ID: 26405196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.
    Tominaga K; Shimamura T; Kimura N; Murayama T; Matsubara D; Kanauchi H; Niida A; Shimizu S; Nishioka K; Tsuji EI; Yano M; Sugano S; Shimono Y; Ishii H; Saya H; Mori M; Akashi K; Tada KI; Ogawa T; Tojo A; Miyano S; Gotoh N
    Oncogene; 2017 Mar; 36(9):1276-1286. PubMed ID: 27546618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases.
    Zhao Y; Bao Q; Schwarz B; Zhao L; Mysliwietz J; Ellwart J; Renner A; Hirner H; Niess H; Camaj P; Angele M; Gros S; Izbicki J; Jauch KW; Nelson PJ; Bruns CJ
    Stem Cells Dev; 2014 Jan; 23(2):180-92. PubMed ID: 24021093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
    Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
    Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of ID1 expression in colon cancer cells increases sensitivity to 5-fluorouracil.
    Przybyła T; Sakowicz-Burkiewicz M; Maciejewska I; Bielarczyk H; Pawełczyk T
    Acta Biochim Pol; 2017; 64(2):315-322. PubMed ID: 28510612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression.
    Xu WW; Li B; Guan XY; Chung SK; Wang Y; Yip YL; Law SY; Chan KT; Lee NP; Chan KW; Xu LY; Li EM; Tsao SW; He QY; Cheung AL
    Nat Commun; 2017 Feb; 8():14399. PubMed ID: 28186102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.
    Shi H; Mao Y; Ju Q; Wu Y; Bai W; Wang P; Zhang Y; Jiang M
    Int J Oncol; 2018 Jul; 53(1):167-176. PubMed ID: 29658564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin-induced alterations in nucleotide metabolism cause 5-fluorouracil resistance but gemcitabine susceptibility in oesophageal squamous cell carcinoma.
    Mynhardt C; Damelin LH; Jivan R; Peres J; Prince S; Veale RB; Mavri-Damelin D
    J Cell Biochem; 2018 Jan; 119(1):1193-1203. PubMed ID: 28722177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.